High Tide Inc. Form 6-K Filing Summary

High Tide Inc. filed a Form 6-K report for the month of June 2026, including unaudited condensed interim consolidated financial statements for the three and six months ended April 30, 2026 and 2025. The financial statements detail the company's financial position, income (loss), comprehensive income (loss), changes in equity, and cash flows. Key financial highlights include revenue of $179,296 for the three months ended April 30, 2026, and $357,625 for the six months ended April 30, 2026. The company reported a net income of $24 for the three months ended April 30, 2026, and a net loss of $328 for the six months ended April 30, 2026. Significant events include the acquisition of 51% of Remexian Pharma GmbH and the issuance of convertible debt. The company operates in a retail-focused cannabis market with diversified operations including bricks-and-mortar retail, European importation, wholesale of medical cannabis, and global e-commerce platforms. Financial risks include credit, liquidity, interest, and market risk, which are managed by the company's risk management program.